首页> 外文期刊>BMC Infectious Diseases >Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients
【24h】

Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients

机译:曲霉菌PCR检测支气管肺泡灌洗液以检测免疫功能低下患者的侵袭性肺曲霉病

获取原文
           

摘要

Background Invasive fungal disease (IFD) is a frequent and serious infectious complication in immunocompromised patients. Culture and cytology in bronchoalveolar lavage (BAL) have a high specificity but low sensitivity for the diagnosis of IFD as assessed by histology. Molecular methods are expected to allow a rapid diagnosis of IFD with a high sensitivity. We evaluated the diagnostic accuracy of conventional nested PCR in the bronchoalveolar fluid to diagnose IFD in severely immunocompromised patients. Methods Consecutive immunosuppressed patients undergoing bronchoscopy for suspected pulmonary infection in a tertiary care hospital were included. Patients were classified as having “proven”, “probable”, “possible”, and “no” IFD based on definitions of the European Organization for Research and Treatment of Cancer and National Institute of Allergy and Infectious Diseases (EORTC/NIAID) and on clinical grounds. Conventional nested PCR for aspergillus fumigatus, flavus, niger, glaucus, terreus and tomarrii were applied to 2.5 ml bronchoalveolar fluid. Results A total of 191 patients were included. Mean age was 51 y, 61% were male. There were 129 patients with hematological conditions, 26 solid organ transplant recipients, 24 auto-immune disorders, and 12 HIV. According to the EORTC/NIAID classification, there were 53 patients with potential IFD: 3 (2%) had proven, 8 (4%) probable, 42 (22%) possible and 138 (72%) no IFD. A total of 111 (58%) of the patients - 10 (90.9%) proven or probable IFD, 32 (76.2%) possible IFD and 69 (50%) “no” IFD) were on anti-fungal therapy at the time of bronchoscopy. Conventional nested PCR for Aspergillus was positive in 55 cases (28.8%). According to these results, sensitivity, specificity, PPV and NPV for “proven” IFD was 0%, 71%, 0%, 98%, respectively and “probable” IFD was 36%, 72%, 7%, 95%, respectively. In 53 (28%) cases there was a strong clinical suspicion of IFD in the chest-x-ray and/or chest-CT irrespective of the EORTC/NIAID classification. However, from those, only 15 (28%) had a positive conventional nested PCR. Conclusion In our experience, conventional nested Aspergillus PCR in the BAL seems to be of limited usefulness for detection of invasive fungal disease in immunocompromised patients due to the limited sensitivity and specificity of the method.
机译:背景技术侵袭性真菌病(IFD)是免疫功能低下患者的一种常见且严重的感染性并发症。通过组织学评估,支气管肺泡灌洗(BAL)中的培养和细胞学对IFD的诊断具有高特异性,但敏感性较低。期望分子方法能够以高灵敏度快速诊断IFD。我们评估了支气管肺泡液中常规巢式PCR诊断严重免疫功能低下患者的IFD的诊断准确性。方法包括在三级医院连续接受免疫抑制的可疑肺部感染接受支气管镜检查的患者。根据欧洲癌症研究与治疗组织和美国过敏与传染病研究所(EORTC / NIAID)的定义,将患者分为具有“已证实”,“可能”,“可能”和“否” IFD的患者临床依据。将传统的烟曲霉,黄曲霉,黑曲霉,青光眼,畸胎瘤和tomarrii的巢式PCR应用于2.5 ml支气管肺泡液。结果共纳入191例患者。平均年龄为51岁,男性占61%。有129例血液学疾病患者,26例实体器官移植患者,24例自身免疫性疾病和12例HIV。根据EORTC / NIAID分类,有53例潜在IFD患者:3例(2%)已被证实,8例(4%)可能,42例(22%)可能,138例(72%)无IFD。共有111位患者(58%)-在确诊时有10%(90.9%)证实或可能的IFD,32位(76.2%)可能的IFD和69位(50%)“无” IFD接受抗真菌治疗。支气管镜检查。常规巢式PCR检测曲霉菌阳性55例(28.8%)。根据这些结果,“经过验证的” IFD的敏感性,特异性,PPV和NPV分别为0%,71%,0%,98%,“可能的” IFD分别为36%,72%,7%,95% 。在53例(28%)病例中,无论EORTC / NIAID分类如何,在X线胸片和/或胸部CT上都强烈怀疑有IFD。但是,只有15例(28%)的常规巢式PCR阳性。结论根据我们的经验,由于该方法的敏感性和特异性有限,BAL中常规的嵌套曲霉PCR在检测免疫功能低下患者的侵袭性真菌疾病方面似乎用途有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号